Chemical inhibition of AKR1C3, such as with the indomethacin inhibitor, has been shown to restore sensitivity to radiation in acquired tumor cells, highlighting AKR1C3 as a potential target for overcoming radioresistance (Sun et al., 2016). The gene discussed is AKR1C3; the disease is neoplasm.